Masayuki Chuma

766 total citations
50 papers, 522 citations indexed

About

Masayuki Chuma is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Masayuki Chuma has authored 50 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Masayuki Chuma's work include Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Biomedical Ethics and Regulation (6 papers). Masayuki Chuma is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Biomedical Ethics and Regulation (6 papers). Masayuki Chuma collaborates with scholars based in Japan, United States and Taiwan. Masayuki Chuma's co-authors include Yoshito Zamami, Keisuke Ishizawa, Mitsuhiro Goda, Kenshi Takechi, Naoto Okada, Takahiro Niimura, Masaki Imanishi, Kenta Yagi, Hirofumi Hamano and Yuki Izawa‐Ishizawa and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Masayuki Chuma

46 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masayuki Chuma Japan	14	196	121	82	73	66	50	522
Sameh R. Abul‐Ezz United States	14	179 0.9×	111 0.9×	133 1.6×	52 0.7×	63 1.0×	26	800
Huang-Yang Chen Taiwan	13	148 0.8×	104 0.9×	82 1.0×	33 0.5×	93 1.4×	19	555
Cheryl D. Cropp United States	15	186 0.9×	65 0.5×	139 1.7×	75 1.0×	50 0.8×	29	599
Azemi Barama Canada	14	212 1.1×	84 0.7×	67 0.8×	27 0.4×	66 1.0×	28	672
Chantal Barin‐Le Guellec France	14	128 0.7×	41 0.3×	115 1.4×	102 1.4×	64 1.0×	36	545
Nassim Djebli France	14	158 0.8×	41 0.3×	125 1.5×	77 1.1×	65 1.0×	30	678
Diogo Diniz Gomes Bugano Brazil	14	107 0.5×	168 1.4×	69 0.8×	68 0.9×	72 1.1×	27	557
Ming-Ju Wu Taiwan	14	77 0.4×	74 0.6×	90 1.1×	30 0.4×	61 0.9×	31	626
Kevin Yau Canada	12	98 0.5×	76 0.6×	118 1.4×	37 0.5×	73 1.1×	33	561
Dinko Rekić Sweden	11	78 0.4×	143 1.2×	57 0.7×	23 0.3×	66 1.0×	29	451

Countries citing papers authored by Masayuki Chuma

Since Specialization

Citations

This map shows the geographic impact of Masayuki Chuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Chuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Chuma more than expected).

Fields of papers citing papers by Masayuki Chuma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Chuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Chuma. The network helps show where Masayuki Chuma may publish in the future.

Co-authorship network of co-authors of Masayuki Chuma

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Chuma. A scholar is included among the top collaborators of Masayuki Chuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Chuma. Masayuki Chuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miyata, Kôji, Yuki Izawa‐Ishizawa, Masateru Kondo, et al.. (2024). Unveiling the association between fluoroquinolones and aortic diseases using real-world database analysis and pharmacological experiments. Biomedicine & Pharmacotherapy. 179. 117418–117418. 1 indexed citations

Hamano, Hirofumi, Takahiro Niimura, Aya Ozaki, et al.. (2023). Association between immune checkpoint inhibitor‐induced myocarditis and concomitant use of thiazide diuretics. International Journal of Cancer. 153(8). 1472–1476. 8 indexed citations

Chuma, Masayuki, Takahiro Niimura, Yutaka Kondo, et al.. (2022). Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis. Clinical Infectious Diseases. 75(8). 1416–1422. 21 indexed citations

Goda, Mitsuhiro, Kôji Miyata, Fuka Aizawa, et al.. (2022). Discovery of preventive drugs for cisplatin‐induced acute kidney injury using big data analysis. Clinical and Translational Science. 15(7). 1664–1675. 5 indexed citations

Zamami, Yoshito, Takahiro Niimura, Takehiro Kawashiri, et al.. (2022). Identification of prophylactic drugs for oxaliplatin-induced peripheral neuropathy using big data. Biomedicine & Pharmacotherapy. 148. 112744–112744. 14 indexed citations

Yagi, Kenta, Yoshito Zamami, Takahiro Niimura, et al.. (2022). Investigation of drugs for the prevention of doxorubicin-induced cardiac events using big data analysis. European Journal of Pharmacology. 928. 175083–175083. 11 indexed citations

Mikami, Takahisa, Takahiro Niimura, Yoshito Zamami, et al.. (2021). The Risk Factors Associated with Immune Checkpoint Inhibitor-Related Pneumonitis. Oncology. 99(4). 256–259. 20 indexed citations

Takechi, Kenshi, Takahiro Niimura, Masayuki Chuma, et al.. (2021). Examination of the antiepileptic effects of valacyclovir using kindling mice― search for novel antiepileptic agents by drug repositioning using a large medical information database. European Journal of Pharmacology. 902. 174099–174099. 2 indexed citations

Sakaguchi, Satoshi, et al.. (2021). Research Ethics Consultation in Nursing Studies. Journal of Empirical Research on Human Research Ethics. 17(1-2). 63–69. 2 indexed citations

10.

Kimura, Toshimi, Yukihiro Hamada, Takashi Niwa, et al.. (2021). Candidates for area under the concentration–time curve (AUC)-guided dosing and risk reduction based on analyses of risk factors associated with nephrotoxicity in vancomycin-treated patients. Journal of Global Antimicrobial Resistance. 27. 12–19. 18 indexed citations

11.

Maeda, Kazuki, et al.. (2020). Introduction of Clinical Trial Document Support System for Document Management of Registration Trials: Outcome Evaluation in a Japanese University Hospital. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 51(2). 77–81.

12.

Yagi, Kenta, Kazuki Maeda, Satoshi Sakaguchi, et al.. (2020). Status of Institutional Review Board Meetings Conducted Through Web Conference Systems in Japanese National University Hospitals During the COVID-19 Pandemic: Questionnaire Study. Journal of Medical Internet Research. 22(11). e22302–e22302. 1 indexed citations

13.

Chuma, Masayuki, Makoto Makishima, Toru Imai, et al.. (2019). Relationship between hemoglobin levels and vancomycin clearance in patients with sepsis. European Journal of Clinical Pharmacology. 75(7). 929–937. 7 indexed citations

14.

Hamano, Hirofumi, Takahiro Niimura, Yuya Horinouchi, et al.. (2019). Proton pump inhibitors block iron absorption through direct regulation of hepcidin via the aryl hydrocarbon receptor-mediated pathway. Toxicology Letters. 318. 86–91. 26 indexed citations

15.

Okada, Naoto, Hitoshi Kawazoe, Kenshi Takechi, et al.. (2018). Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study. Clinical Therapeutics. 41(1). 59–67. 85 indexed citations

16.

Hamano, Hirofumi, Yoshito Zamami, Kenshi Takechi, et al.. (2018). Irinotecan-induced neutropenia is reduced by oral alkalization drugs: analysis using retrospective chart reviews and the spontaneous reporting database. Supportive Care in Cancer. 27(3). 849–856. 15 indexed citations

17.

Yanagawa, Hiroaki, et al.. (2018). Research ethics consultation: an attempt and 5-year experience in a Japanese University Hospital. BMC Research Notes. 11(1). 665–665. 3 indexed citations

18.

Sato, Shiho, Yoshito Zamami, Toru Imai, et al.. (2017). Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia. Scientific Reports. 7(1). 12683–12683. 7 indexed citations

19.

Chuma, Masayuki, et al.. (2016). Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis. Clinical Therapeutics. 38(12). 2598–2609. 12 indexed citations

20.

Chuma, Masayuki, et al.. (2010). Factors Associated with Neurotoxicity in Patients Receiving FOLFOX 4. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 36(5). 347–351. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact